OMNIAB, INC. Other Operating Income (Expense), Net
OMNIAB, INC. (OABI) reported Other Operating Income (Expense), Net of -$150.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherOperatingIncomeExpenseNet · last filed 2026-08-06
- OMNIAB, INC. other operating income (expense), net for the quarter ending 2026-06-30 was -$150.00K, a 107.80% decline year-over-year.
- OMNIAB, INC. other operating income (expense), net for the quarter ending 2026-03-31 was $46.00K, a 93.87% decline year-over-year.
- OMNIAB, INC. other operating income (expense), net for the quarter ending 2025-12-31 was -$157.00K, a 482.93% decline year-over-year.
- OMNIAB, INC. other operating income (expense), net for the quarter ending 2025-09-30 was $34.00K.
- OMNIAB, INC. other operating income (expense), net for fiscal 2025 was $2.55M, a 7.78% increase from fiscal 2024.
- OMNIAB, INC. other operating income (expense), net for fiscal 2024 was $2.37M.
- OMNIAB, INC. other operating income (expense), net for fiscal 2023 was -$191.00K, a 132.26% decline from fiscal 2022.
- OMNIAB, INC. other operating income (expense), net for fiscal 2022 was $592.00K.
| Period end | Other Operating Income (Expense), Net 3 month | Other Operating Income (Expense), Net 3 month as first filed | Other Operating Income (Expense), Net 6 month | Other Operating Income (Expense), Net 9 month | Other Operating Income (Expense), Net 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$150.00K 10-Q · filed 2026-08-06 | -$104.00K 10-Q · filed 2026-08-06 | -$261.00K derived: sum of 3 quarters · filed 2026-08-06 | -$227.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $46.00K 10-Q · filed 2026-05-07 | -$111.00K derived: sum of 2 quarters · filed 2026-05-07 | -$77.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.84M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$157.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$123.00K derived: sum of 2 quarters · filed 2026-03-04 | $1.80M derived: sum of 3 quarters · filed 2026-08-06 | $2.55M 10-K · filed 2026-03-04 | |
| 2025-09-30 | $34.00K 10-Q · filed 2025-11-04 | $1.96M derived: sum of 2 quarters · filed 2026-08-06 | $2.71M 10-Q · filed 2025-11-04 | $2.75M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $1.92M 10-Q · filed 2026-08-06 | $2.67M 10-Q · filed 2026-08-06 | $2.71M derived: sum of 3 quarters · filed 2026-08-06 | $2.57M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $750.00K 10-Q · filed 2026-05-07 | $747.00K 10-Q · filed 2025-05-08 | $791.00K derived: sum of 2 quarters · filed 2026-05-07 | $645.00K derived: sum of 3 quarters · filed 2026-05-07 | $3.17M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$105.00K derived: sum of 2 quarters · filed 2026-03-04 | $2.42M derived: sum of 3 quarters · filed 2026-03-04 | $2.37M 10-K · filed 2026-03-04 | |
| 2024-09-30 | -$146.00K 10-Q · filed 2025-11-04 | $2.38M derived: sum of 2 quarters · filed 2025-11-04 | $2.32M 10-Q · filed 2025-11-04 | $2.34M derived: sum of 4 quarters · filed 2025-11-04 | |
| 2024-06-30 | $2.52M 10-Q · filed 2025-08-06 | $2.47M 10-Q · filed 2025-08-06 | $2.48M derived: sum of 3 quarters · filed 2025-08-06 | $2.47M derived: sum of 4 quarters · filed 2025-08-06 | |
| 2024-03-31 | -$54.00K 10-Q · filed 2025-05-08 | -$40.00K derived: sum of 2 quarters · filed 2025-05-08 | -$56.00K derived: sum of 3 quarters · filed 2025-05-08 | -$196.00K derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$2.00K derived: sum of 2 quarters · filed 2025-03-18 | -$142.00K derived: sum of 3 quarters · filed 2025-03-18 | -$191.00K 10-K · filed 2025-03-18 | |
| 2023-09-30 | -$16.00K 10-Q · filed 2024-11-12 | -$156.00K derived: sum of 2 quarters · filed 2024-11-12 | -$205.00K 10-Q · filed 2024-11-12 | -$99.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$140.00K 10-Q · filed 2024-08-08 | -$189.00K 10-Q · filed 2024-08-08 | -$83.00K derived: sum of 3 quarters · filed 2024-08-08 | $125.00K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$49.00K 10-Q · filed 2024-05-09 | $57.00K derived: sum of 2 quarters · filed 2024-05-09 | $265.00K derived: sum of 3 quarters · filed 2024-05-09 | $100.00K derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $314.00K derived: sum of 2 quarters · filed 2024-03-25 | $149.00K derived: sum of 3 quarters · filed 2024-03-25 | $592.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $208.00K 10-Q · filed 2023-11-09 | $43.00K derived: sum of 2 quarters · filed 2023-11-09 | $486.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$165.00K 10-Q · filed 2023-08-10 | $278.00K 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | $443.00K 10-Q · filed 2023-05-11 | ||||
| 2021-12-31 | -$1.21M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |